Form 4: Enfusion Director Kathleen DeRose Reports Disposal of Shares Following Merger with Clearwater Analytics

Kathleen DeRose, a director at Enfusion, Inc., reported the disposal of 60,716 shares of Class A Common Stock following the company's merger with Clearwater Analytics Holdings, Inc.

Summary

• Kathleen DeRose, a director of Enfusion, Inc., filed a Form 4 to report changes in beneficial ownership.
• The report indicates the disposal of 60,716 shares of Enfusion's Class A Common Stock on April 21, 2025.
• This disposal is a result of the merger agreement between Enfusion and Clearwater Analytics Holdings, Inc.
• Under the merger terms, each eligible share of Enfusion's Class A common stock was converted into the right to receive cash, shares of Clearwater Analytics Class A common stock, or a combination thereof.
• Following the merger, DeRose no longer beneficially owns any securities of Enfusion, marking this as an exit filing.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment as it primarily reports a transaction resulting from a merger. There are no explicit positive or negative implications for either company.

Future Outlook

The document does not contain any forward-looking statements regarding the future outlook of Clearwater Analytics or Enfusion.

Industry Context

This announcement reflects the ongoing consolidation within the financial technology sector, where companies are merging to expand their service offerings and market reach. Clearwater Analytics' acquisition of Enfusion is likely aimed at strengthening its position in the investment management software space.

Stakeholder Impact

• Shareholders of Enfusion received consideration in the form of cash, Clearwater Analytics shares, or a combination thereof, as per the merger agreement.

Key Dates

Keywords

Enfusion, Clearwater Analytics, Merger, Form 4, Beneficial Ownership, DeRose, Shares, ENFN